Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein S29 pseudogene 3 (RPS29P3, also known as bcm2758) is a processed pseudogene in the human genome, meaning it is a non-functional genomic DNA sequence similar to the functional ribosomal protein S29 gene but lacks coding capacity due to accumulated mutations or truncations. RPS29P3 does not encode a functional protein and is not known to have a biological role, molecular function, or relevance as a therapeutic target. It exists as part of the numerous pseudogenes derived from the ribosomal protein S29 gene, with no associated disease roles, drug interactions, or known functions[2][3][5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein S29 pseudogene 3 (RPS29P3).